Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #JCOCCI https://t.co/O3gbuP0GZJ #lcsm #PrecisionMedicine #hpeonc Pts 2011-2016, multi panel testing vs single gene testing -> mo
Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #JCOCCI https://t.co/O3gbuP0GZJ #lcsm #PrecisionMedicine #hpeonc Pts 2011-2016, multi panel testing vs single gene testing -> mo
RT @n8pennell: Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2…
RT @n8pennell: Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2…
RT @n8pennell: Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2…
RT @n8pennell: Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2…
RT @n8pennell: Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2…
Cost Effectiveness of Multigene Panel Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer #LCSM https://t.co/p2l7o7bWyJ
Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #JCOCCI https://t.co/O3gbuP0GZJ #lcsm #PrecisionMedicine #hpeonc Pts 2011-2016, multi panel testing vs single gene testing -> mo
RT @cancer_evolve: Two recent studies in NSCLC show that upfront multigene panel is more cost efficient that iterative single gene testing.…
RT @Pillar_Bio: Study of 5000 patient outcomes shows that multi-gene NGS panels are moderately more cost effective for #NSCLC patients than…
Study of 5000 patient outcomes shows that multi-gene NGS panels are moderately more cost effective for #NSCLC patients than single-gene marker tests. https://t.co/EBqWzi7o5t https://t.co/i2VWGRnhie
RT @cancer_evolve: Two recent studies in NSCLC show that upfront multigene panel is more cost efficient that iterative single gene testing.…
RT @cancer_evolve: Two recent studies in NSCLC show that upfront multigene panel is more cost efficient that iterative single gene testing.…
Two recent studies in NSCLC show that upfront multigene panel is more cost efficient that iterative single gene testing. Multigene genomic assays also allow more parsimonious use of scarce biopsy material. https://t.co/KPcy7FlqEy https://t.co/UMdix6UzLy
RT @mtmdphd: Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al.…
Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #JCOCCI https://t.co/O3gbuP0GZJ #lcsm #PrecisionMedicine #hpeonc Pts 2011-2016, multi panel testing vs single gene testing -> m
So nice when your bestie is mentioned in the news. Daryl Pritchard, the thumb of The Hand and senior VP of science policy at the Personalized Medicine Coalition co-authored this study: https://t.co/xycrd5WfOs
RT @mtmdphd: Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #…
Cost Effectiveness of Multigene Panel Sequencing for Advanced Non–Small-Cell Lung Cancer [Jun 26, 2019] @LotteSteuten et al. #JCOCCI https://t.co/O3gbuP0GZJ #lcsm #PrecisionMedicine #hpeonc Pts 2011-2016, multi panel testing vs single gene testing -> m
RT @JCO_ASCO: In new #JCOCCI review, Dr. Steuten of @fredhutch et al. estimated the clinical and cost-effectiveness of Multi-Gene Panel Seq…
@OncoAlert @isliquidbiopsy
RT @JCO_ASCO: In new #JCOCCI review, Dr. Steuten of @fredhutch et al. estimated the clinical and cost-effectiveness of Multi-Gene Panel Seq…
RT @JCO_ASCO: In new #JCOCCI review, Dr. Steuten of @fredhutch et al. estimated the clinical and cost-effectiveness of Multi-Gene Panel Seq…
In new #JCOCCI review, Dr. Steuten of @fredhutch et al. estimated the clinical and cost-effectiveness of Multi-Gene Panel Sequencing vs. single-marker genetic testing among patients with advanced #NSCLC https://t.co/8j5L2M7G91 https://t.co/weKfnxnuz8